Boehringer Ingelheim Unveils New £150 Million Artificial Intelligence and Machine Learning Hub in London, Reinforcing UK’s Life Sciences Ambition
Boehringer Ingelheim, a leading research-driven pharmaceutical company, has officially inaugurated a significant new artificial intelligence (AI) and machine learning (ML)...
June 18, 2025